Delivery Order SPE2DR25D6028-SPE2DR26FASHN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,151.89 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count packages), with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.78 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablets) 8mg in a quantity of 30 units. This non-competitive, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of the same day. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $36,336.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4MG tablets (30-count supply) on December 17, 2025, with an ultimate completion date of January 15, 2026. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,849.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Ondansetron 8mg tablets (30-count units) on November 24, 2025, with completion required by December 22, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $12,625.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packages) on November 13, 2025, with completion targeted for November 14, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $5,595.36 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ondansetron Orally Disintegrating Tablets 8mg in a 30-count package. The contract, which is a firm fixed price delivery order with no set-aside designation, is set for completion by October 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,375.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count configuration. The delivery order, which represents a non-set-aside competitive award, is scheduled for ultimate completion by December 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,006.46 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on October 31, 2025, with completion expected by November 3, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a $5,629.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,662.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASHNDelivery Order
The Defense Logistics Agency awarded a $9,546.68 delivery order to AmerisourceBergen Drug Corp for Ondansetron Orally Disintegrating Tablets (8mg, 30-count package) on December 3, 2025, with completion by December 4, 2025. This non-competitive delivery order employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime contract vehicle valued through December 2026 that supports comprehensive global pharmaceutical supply operations for military healthcare programs. The IDC enables the contractor to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This order for ondansetron, an anti-nausea medication commonly used in clinical settings, represents a routine pharmaceutical procurement supporting ongoing federal healthcare operations.